IGF1 and pancreatic neoplasm: Some researchers found that insulin-like growth factor-I (IGF-I)-mediated progression of pancreatic cancer cells depended on c-Met, and the down-regulation of c-Met almost completely inhibited the tumorigenic effect of IGF-I (Yang et al., 2020).